ALAMEDA, Calif. — CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates non-viral and viral approaches to cell therapy engineering. This next-generation process aims to enable streamlined workflows of complex edited cells for biotech and pharmaceutical […]
Dr Jose-Carlos Gutiérrez-Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public markets He brings a wealth of experience across biotechs and pharmaceutical companies, combined with […]
World’s Most Comprehensive Protein Study Highlights Ultima’s Commitment to Unlocking the Power of Genomics at Scale FREMONT, Calif. — Ultima Genomics, Inc., a developer of an ultra-high throughput next-generation sequencing (NGS) platform, today announced that its UG 100™ was selected as the sequencing platform to enable UK Biobank’s unprecedented protein study, which will be the world’s largest […]
London, UK – LGC has today announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and Chief Executive Officer (CEO). Joydeep succeeds Euan O’Sullivan, who decided to step down from his role in early 2024 after fourteen years of outstanding and dedicated service. Euan has worked closely with […]
ResolveSEQ MRD offers paired single cell genome and transcriptome characterization for discovering novel prognostic and therapeutic signatures in MRD cells New Certified Service Provider (CSP) Program will enable broader access to BioSkryb’s technology Durham, N.C. – BioSkryb Genomics, a pioneer in single-cell and ultra-low input multiomics is excited to announce the launch of ResolveSEQ MRD, an […]
ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation, today announced that Seattle Children’s Therapeutics, a division of the Seattle Children’s Research Institute has been awarded a $125,000 G-Rex Grant. The G-Rex Grant will integrate state-of-the-art advancements into Seattle Children’s Therapeutics’ G-Rex based CAR-T cell platform. “This technology has been a […]
Appointment signals acceleration of organic and inorganic growth for VION as it looks to expand in 2025 CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, today announced Vince Stoyanov as its Chief Strategy and Development Officer. He will lead […]
Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for Advanced Rare and Complex Cell Sorting in Flow Processes Pioneering industry collaboration: Bracco and Aenitis join forces to combine expertise in acoustophoresis and functionalised microsystems to revolutionise the sorting of rare and complex cells, driving innovation in biomanufacturing and advanced therapies Transformative alternative for sorting rare […]
SAN DIEGO, CA and OXFORD, UK –Oxford Nanoimaging (ONI), a life science tools company focused on developing super-resolution microscopy, announced today the launch of the Aplo Scope, a single molecule super-resolution microscope that enables scientists to observe and measure molecular interactions within cells and tissues with unparalleled precision. The Aplo Scope addresses a critical challenge in single-molecule […]
Berry Genomics will leverage PacBio Vega System to develop long-read sequencing-based solutions for patients in China and other countries MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry Genomics as part of an early access agreement announced in 2022. Under the terms […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
